2025 年全球基因傳遞技術市場報告

預計未來幾年基因轉移技術的市場規模將快速成長。到 2029 年，這一數字將成長至 74.4 億美元，複合年成長率為 14.7%。預測期內的成長可歸因於精準醫療的發展、法規結構的加強、基因治療的廣泛應用以及非病毒遞送系統的擴展。預測期內的主要趨勢包括罕見疾病應用、增加臨床試驗、標靶藥物傳遞、細胞療法的擴展以及基因編輯工具的開發。

細胞和基因治療的日益普及預計將推動基因轉移技術市場未來的成長。細胞和基因療法是治療方法。這些治療方法的興起很大程度上是由基因編輯技術的進步所推動的，基因編輯技術在細胞和基因治療方法的開發和商業化中發揮關鍵作用。例如，根據英國工業組織英國製藥核准協會的數據，截至 2024 年 8 月，英國藥品監管機構平均每年核准兩種先進治療藥物 (ATMP)。然而，到 2030 年，這一數字預計將增加到每年 10 至 15 例。此外，到 2028 年，英國接受此類治療的患者數量可能會從 2021 年的 2,500 人增加到每年 10,000 人。因此，細胞和基因治療的興起是推動基因轉殖技術市場的關鍵因素。

個人化醫療日益成長的需求預計將在未來幾年推動基因轉移技術市場的成長。精準醫療是指一種客製化的醫療保健方法，考慮到患者的遺傳、環境和生活方式等個別特徵，以提高治療效果和結果。多種因素導致個人化醫療的需求不斷增加，包括基因組學的進步、患者權利的增強和治療效果的改善。基因傳遞技術可以精確地瞄準特定的細胞和組織，確保僅在需要的地方進行治療。例如，2024年2月，美國非營利組織個人化醫療聯盟報告稱，FDA將在2023年核准16種針對罕見疾病患者的新型個人化治療方法，而2022年僅有6種。因此，個人化醫療需求的不斷成長是基因轉移技術市場的關鍵驅動力。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第 4 章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情以及復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球基因轉移技術市場的 PESTEL 分析（政治、社會、技術、環境、法律、促進因素、限制因素）
• 最終用途產業分析
• 全球基因傳遞技術市場：成長率分析
• 全球基因傳遞技術市場表現：規模與成長，2019 年至 2024 年
• 全球基因傳遞技術市場預測：規模與成長，2024-2029 年，2034 年
• 全球基因傳遞技術總目標市場 (TAM)

第6章 市場細分

• 全球基因傳遞技術市場（按模式、表現和預測），2019-2024 年、2024-2029 年、2034 年
• 生物
• 化學
• 身體的
• 全球基因傳遞技術市場（依方法、效能與預測），2019-2024 年、2024-2029 年、2034 年
• 體外
• 體內
• 試管內
• 全球基因傳遞技術市場的應用、效能與預測，2019-2024、2024-2029、2034
• 基因治療
• 細胞療法
• 疫苗
• 研究
• 全球基因傳遞技術市場：按類型、表現和預測進行生理細分，2019-2024 年、2024-2029 年、2034 年
• 病毒載體
• 細菌載體
• 脂質奈米顆粒
• 全球基因傳遞技術市場：按類型、性能和預測的化學細分，2019-2024 年、2024-2029 年、2034 年
• 陽離子脂質
• 聚合物
• 化學轉染劑
• 全球基因傳遞技術市場：按類型、表現和預測進行實體細分，2019-2024 年、2024-2029 年、2034 年
• 電穿孔
• 顯微注射
• 吉恩·甘
• Sonoporation

第7章 區域和國家分析

• 全球基因傳遞技術市場各地區、表現及預測，2019-2024、2024-2029、2034
• 全球基因傳遞技術市場（按國家/地區分類）、表現和預測，2019-2024、2024-2029、2034

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第 17 章 德國市場

第 18 章 法國市場

第 19 章：義大利市場

第 20 章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第 25 章：加拿大市場

第26章 南美洲市場

第 27 章：巴西市場

第28章 中東市場

第 29 章：非洲市場

第 30 章競爭格局與公司概況

• 基因傳遞技術市場：競爭格局
• 基因轉殖技術市場：公司簡介
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • QIAGEN NV Overview, Products and Services, Strategy and Financial Analysis
  • Horizon Discovery Group Co Overview, Products and Services, Strategy and Financial Analysis
  • OriGene Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Oxford Biomedica Solutions LLC Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• SignaGen Laboratories LLC
• Vectalys SAS
• Takara Bio Inc.
• Bio-Rad Laboratories Inc.
• System Biosciences LLC
• Promega Corporation
• Hoffmann-La Roche AG
• Catalent Inc.
• Avantor
• Pfizer Inc.
• Becton Dickinson and Company
• Novartis AG
• Intellia Therapeutics Inc.
• Editas Medicine Inc.
• CRISPR Therapeutics AG

第 32 章 全球市場競爭基準化分析與儀表板

第33章 重大併購

第 34 章 近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029 年基因轉殖技術市場：提供新機會的國家
• 基因傳遞技術市場 2029：提供新機會市場
• 基因傳遞技術市場 2029：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第 36 章 附錄

Gene delivery technologies encompass methods utilized to introduce foreign genetic material, such as DNA or RNA, into cells, aiming to transfer the genetic material into the target cells. These technologies are commonly employed in the treatment of diseases or disorders resulting from altered genes, such as mutations or inherited genetic anomalies.

The primary types of gene delivery technologies modes include biological, chemical, and physical approaches. Biological methods involve the use of living organisms or their derivatives in the development and delivery of gene therapy products. Various techniques, such as ex vivo, in vivo, and in vitro applications, are employed in gene therapy, cell therapy, vaccines, and research.

The gene delivery technologies market research report is one of a series of new reports from The Business Research Company that provides gene delivery technologies market statistics, including gene delivery technologies industry global market size, regional shares, competitors with a gene delivery technologies market share, detailed gene delivery technologies market segments, market trends and opportunities, and any further data you may need to thrive in the gene delivery technologies industry. This gene delivery technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gene delivery technologies market size has grown rapidly in recent years. It will grow from$3.79 billion in 2024 to $4.3 billion in 2025 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to enhanced understanding of genetic diseases, advancements in cell therapy, evolution of nanotechnology, growth of gene therapy trials, research funding increase

The gene delivery technologies market size is expected to see rapid growth in the next few years. It will grow to $7.44 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to precision medicine development, regulatory framework enhancements, proliferation of gene therapy, expansion of non-viral delivery systems. Major trends in the forecast period include application in rare diseases, rise in clinical trials, targeted drug delivery, expansion of cell therapy, development of gene editing tools.

The growing prevalence of cell and gene therapies is projected to drive the growth of the gene delivery technologies market in the future. Cell and gene therapies are medical treatments designed to cure or alleviate diseases by modifying the genetic and cellular composition of a patient's body. The rise in these therapies is largely fueled by advancements in gene editing technologies, which play a crucial role in the development and commercialization of cell and gene therapies. For example, in August 2024, the Association of the British Pharmaceutical Industry, a UK-based trade association, reported that the UK medicines regulator has historically approved an average of two advanced therapy medicinal products (ATMPs) annually. However, this number is expected to increase to 10-15 approvals per year by 2030. Additionally, the number of patients receiving these therapies in the UK could grow from 2,500 in 2021 to as many as 10,000 annually by 2028. Therefore, the rise in cell and gene therapies is a key factor driving the gene delivery technologies market.

The rising demand for personalized medicine is expected to drive the growth of the gene delivery technologies market in the future. Personalized medicine refers to a tailored healthcare approach that considers individual patient characteristics, such as genetics, environment, and lifestyle, to improve treatment effectiveness and outcomes. Several factors are contributing to the increased demand for personalized medicine, including advancements in genomics, greater patient empowerment, and enhanced treatment efficacy. Gene delivery technologies allow for the precise targeting of specific cells or tissues, ensuring that therapies are administered only where needed, which helps to minimize side effects and maximize therapeutic effectiveness. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, compared to just six in 2022. Thus, the growing demand for personalized medicine is a significant driver of the gene delivery technologies market.

Technological advancement has become a prominent trend in the gene delivery technologies market. Major players in the market are directing their efforts toward the development of advanced products to fortify their market positions. For instance, in February 2023, Aera Therapeutics, a US-based biotechnology company, introduced Aera's Platform delivery technology, aiming to unlock the potential of genetic medicines. Aera's PNP technology facilitates precise targeting of RNA molecules implicated in disease processes, enabling the targeted editing of genes in a patient's cells and offering potential for personalized gene therapies.

Leading companies in gene delivery technologies are concentrating on the development of advanced products, such as the ProteoAnalyzer, to achieve a competitive advantage in the market. The ProteoAnalyzer is a sophisticated automated system created by Agilent Technologies specifically for protein analysis, utilizing parallel capillary electrophoresis (CE) technology. For example, in July 2024, Agilent Technologies Inc., a life sciences company based in the US, launched the ProteoAnalyzer system. This innovative platform is designed for automated parallel capillary electrophoresis, allowing for rapid and high-resolution protein analysis with minimal sample consumption. This feature is especially advantageous for researchers dealing with complex protein mixtures in pharmaceuticals, biopharma, and bioengineered food ingredients, enabling quicker discoveries and advancements in translational research. The system facilitates detailed analysis of protein mixtures, which is essential for the development of therapeutic proteins.

In January 2024, Kyowa Kirin Co. Ltd., a pharmaceutical company based in Japan, acquired Orchard Therapeutics plc for an undisclosed amount. This acquisition is intended to enhance Kyowa Kirin's gene therapy portfolio by utilizing Orchard Therapeutics' expertise in hematopoietic stem cell (HSC) gene therapies to tackle rare genetic diseases and broaden patient access to transformative treatments. Orchard Therapeutics plc is a biopharmaceutical company located in the UK that specializes in gene therapy.

Major companies operating in the gene delivery technologies market include Thermo Fisher Scientific Inc., QIAGEN NV, Horizon Discovery Group Co, OriGene Technologies Inc., Oxford Biomedica Solutions LLC, SignaGen Laboratories LLC, Vectalys SAS, Takara Bio Inc., Bio-Rad Laboratories Inc., System Biosciences LLC, Promega Corporation, Hoffmann-La Roche AG, Catalent Inc., Avantor, Pfizer Inc., Becton Dickinson and Company, Novartis AG, Intellia Therapeutics Inc., Editas Medicine Inc., CRISPR Therapeutics AG, Spark Therapeutics Inc., Bluebird Bio Inc., Sarepta Therapeutics Inc., Regenexxbio Inc., Beam Therapeutics Inc., Verve Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Moderna Inc., BioNTech SE, Translate Bio Inc., CureVac N.V., Lonza Group AG

North America was the largest region in the gene delivery technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global gene delivery technologies market report during the forecast period. The regions covered in the gene delivery technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the gene delivery technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The gene delivery technologies market consists of revenues earned by entities by providing services such as viral vector production, gene editing, gene therapy, and cell therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Gene delivery technologies also include sales of viral and non-viral vectors, transfection reagents, gene editing tools that are used in providing gene delivery. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gene Delivery Technologies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gene delivery technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gene delivery technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gene delivery technologies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Mode: Biological; Chemical; Physical
• 2) By Method: Ex Vivo; In Vivo; In Vitro
• 3) By Application: Gene Therapy; Cell Therapy; Vaccines; Research
• Subsegments:
• 1) By Biological: Viral Vectors; Bacterial Vectors; Lipid Nanoparticles
• 2) By Chemical: Cationic Lipids; Polymers; Chemical Transfection Agents
• 3) By Physical: Electroporation; Microinjection; Gene Gun; Sonoporation
• Companies Mentioned: Thermo Fisher Scientific Inc.; QIAGEN NV; Horizon Discovery Group Co; OriGene Technologies Inc.; Oxford Biomedica Solutions LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gene Delivery Technologies Market Characteristics

3. Gene Delivery Technologies Market Trends And Strategies

4. Gene Delivery Technologies Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Gene Delivery Technologies Growth Analysis And Strategic Analysis Framework

• 5.1. Global Gene Delivery Technologies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Gene Delivery Technologies Market Growth Rate Analysis
• 5.4. Global Gene Delivery Technologies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Gene Delivery Technologies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Gene Delivery Technologies Total Addressable Market (TAM)

6. Gene Delivery Technologies Market Segmentation

• 6.1. Global Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Biological
• Chemical
• Physical
• 6.2. Global Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ex Vivo
• In Vivo
• In Vitro
• 6.3. Global Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gene Therapy
• Cell Therapy
• Vaccines
• Research
• 6.4. Global Gene Delivery Technologies Market, Sub-Segmentation Of Biological, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Viral Vectors
• Bacterial Vectors
• Lipid Nanoparticles
• 6.5. Global Gene Delivery Technologies Market, Sub-Segmentation Of Chemical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cationic Lipids
• Polymers
• Chemical Transfection Agents
• 6.6. Global Gene Delivery Technologies Market, Sub-Segmentation Of Physical, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Electroporation
• Microinjection
• Gene Gun
• Sonoporation

7. Gene Delivery Technologies Market Regional And Country Analysis

• 7.1. Global Gene Delivery Technologies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Gene Delivery Technologies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gene Delivery Technologies Market

• 8.1. Asia-Pacific Gene Delivery Technologies Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gene Delivery Technologies Market

• 9.1. China Gene Delivery Technologies Market Overview
• 9.2. China Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gene Delivery Technologies Market

• 10.1. India Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gene Delivery Technologies Market

• 11.1. Japan Gene Delivery Technologies Market Overview
• 11.2. Japan Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gene Delivery Technologies Market

• 12.1. Australia Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gene Delivery Technologies Market

• 13.1. Indonesia Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gene Delivery Technologies Market

• 14.1. South Korea Gene Delivery Technologies Market Overview
• 14.2. South Korea Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gene Delivery Technologies Market

• 15.1. Western Europe Gene Delivery Technologies Market Overview
• 15.2. Western Europe Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gene Delivery Technologies Market

• 16.1. UK Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gene Delivery Technologies Market

• 17.1. Germany Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gene Delivery Technologies Market

• 18.1. France Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gene Delivery Technologies Market

• 19.1. Italy Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gene Delivery Technologies Market

• 20.1. Spain Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gene Delivery Technologies Market

• 21.1. Eastern Europe Gene Delivery Technologies Market Overview
• 21.2. Eastern Europe Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gene Delivery Technologies Market

• 22.1. Russia Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gene Delivery Technologies Market

• 23.1. North America Gene Delivery Technologies Market Overview
• 23.2. North America Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gene Delivery Technologies Market

• 24.1. USA Gene Delivery Technologies Market Overview
• 24.2. USA Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gene Delivery Technologies Market

• 25.1. Canada Gene Delivery Technologies Market Overview
• 25.2. Canada Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gene Delivery Technologies Market

• 26.1. South America Gene Delivery Technologies Market Overview
• 26.2. South America Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gene Delivery Technologies Market

• 27.1. Brazil Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gene Delivery Technologies Market

• 28.1. Middle East Gene Delivery Technologies Market Overview
• 28.2. Middle East Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gene Delivery Technologies Market

• 29.1. Africa Gene Delivery Technologies Market Overview
• 29.2. Africa Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Gene Delivery Technologies Market, Segmentation By Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gene Delivery Technologies Market Competitive Landscape And Company Profiles

• 30.1. Gene Delivery Technologies Market Competitive Landscape
• 30.2. Gene Delivery Technologies Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. QIAGEN NV Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Horizon Discovery Group Co Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. OriGene Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Oxford Biomedica Solutions LLC Overview, Products and Services, Strategy and Financial Analysis

31. Gene Delivery Technologies Market Other Major And Innovative Companies

• 31.1. SignaGen Laboratories LLC
• 31.2. Vectalys SAS
• 31.3. Takara Bio Inc.
• 31.4. Bio-Rad Laboratories Inc.
• 31.5. System Biosciences LLC
• 31.6. Promega Corporation
• 31.7. Hoffmann-La Roche AG
• 31.8. Catalent Inc.
• 31.9. Avantor
• 31.10. Pfizer Inc.
• 31.11. Becton Dickinson and Company
• 31.12. Novartis AG
• 31.13. Intellia Therapeutics Inc.
• 31.14. Editas Medicine Inc.
• 31.15. CRISPR Therapeutics AG

32. Global Gene Delivery Technologies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gene Delivery Technologies Market

34. Recent Developments In The Gene Delivery Technologies Market

35. Gene Delivery Technologies Market High Potential Countries, Segments and Strategies

• 35.1 Gene Delivery Technologies Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Gene Delivery Technologies Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Gene Delivery Technologies Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer